Clinical Trials Directory

Trials / Completed

CompletedNCT01233518

Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
285 (actual)
Sponsor
HeartFlow, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective, multi-center trial conducted at up to 20 US, Canadian, European and Asian centers designed to determine the diagnostic performance of CT-FLOW (the investigational technology) by coronary computed tomographic angiography (CCTA) for non-invasive assessment of the hemodynamic significance of coronary lesions, as compared to direct measurement of fractional flow reserve (FFR) during cardiac catheterization as a reference standard.

Detailed description

285 patient, prospective, multi-center trial conducted at up to 20 US, Canadian, European and Asian centers designed to determine the diagnostic performance of CT-FLOW (the investigational technology) by coronary computed tomographic angiography (CCTA) for non-invasive assessment of the hemodynamic significance of coronary lesions, as compared to direct measurement of fractional flow reserve (FFR) during cardiac catheterization as a reference standard

Conditions

Interventions

TypeNameDescription
DEVICEFFRFractional flow reserve measured during cardiac catheterization

Timeline

Start date
2010-10-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2010-11-03
Last updated
2021-02-09
Results posted
2021-01-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01233518. Inclusion in this directory is not an endorsement.